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Abstract
Background: In endemic regions naturally acquired immunity against Plasmodium falciparum develops as a
function of age and exposure to parasite infections and is known to be mediated by IgG. The targets of protective
antibodies remain to be fully defined. Several immunoepidemiological studies have indicated an association of
cytophilic anti-parasite IgG with protection against malaria. It has been hypothesized that the initial antibody
responses against parasite antigens upon first few Plasmodium falciparum infections is dominated by non-
protective IgG2/IgG4 and IgM antibodies, which then gradually develop into protective response dominated by
cytophilic IgG1 and IgG3 antibodies.
Methods: Naturally occurring IgG antibodies against P. falciparum blood-stage antigens were analysed from plasma
samples collected from four groups of individuals differing in age and level of exposure to P. falciparum infections.
Western Blot profiling of blood-stage parasite antigens displaying reactivity with individual plasma samples in terms
of their subclass specificities was conducted. Parasite antigens detected by IgG were grouped based on their
apparent molecular sizes resolved by SDS-PAGE as high molecular weight (≥ 70 kDa) or low molecular weight (<
70 kDa). The number of discernable low molecular weight parasite antigens detected by different IgG subclass
antibodies from each plasma sample was recorded. Using Wilcoxons rank sum test these reactivities were
compared amongst groups of individuals with different levels of exposure to P. falciparum infections.
Results: IgG4 and IgM antibodies in plasma samples from all groups detected very few parasite antigens. IgG2
antibodies from all groups detected a common pattern of high molecular weight parasite antigens. Cytophilic IgG
subclasses in plasma samples from individuals with higher levels of exposure to P. falciparum infections distinctly
detected higher numbers of low molecular weight parasite antigens.
Conclusions: In the present study, there was no evidence for switching of antibody responses from non-cytophilic
to cytophilic subclasses against blood-stage parasite antigens as a likely mechanism for induction of protective
immunity against malaria.
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Immunoepidemiological studies have demonstrated that
immunity against blood stage Plasmodium falciparum is
associated with the acquisition of anti-parasite antibo-
dies of the cytophilic subclasses [1], and in particular
IgG3 [2-9]. No such protective association has been
observed for non-cytophilic subclasses such as IgM and
IgG4 [2,3]. For IgG2 conflicting evidence has been pre-
sented, associating levels of specific IgG2 antibodies
with either an increased frequency of clinical malaria
episodes [1,2,10], or resistance to P. falciparum malaria
[11,12]. It is noteworthy that protection against malaria
by IgG2 has often been associated with the FcgRIIa-
H131 allotype, a receptor point mutation which accords
binding to IgG2 [11,13-16]. These observations support
the importance of cytophilic antibodies in protection
against malaria. It has been hypothesized that develop-
ment of effective IgG-mediated anti-parasite immunity
depends on the maturation of antibody responses, not
only in terms of their antigen specificities and affinity
maturation, but also in terms of class-switching imply-
ing that the progressive development of malaria immu-
nity in older children can be attributed to a switch of
anti-parasite antibodies from the non-cytophilic to the
cytophilic subclasses [3,17]. It has even been proposed
that the non-cytophilic antibodies could compete and
block the protective mechanisms elicited through the
binding of the cytophilic subclasses [17].
The subclass profile of naturally occurring IgG
responses has therefore been extensively studied for sev-
eral major blood-stage malaria vaccine candidate antigens.
These analyses have mainly been carried out by ELISA
using recombinant proteins or synthetic peptides usually
representing subdomains of malarial proteins as test anti-
gens. Such antigen preparations do not always accurately
mimic native parasite protein conformations, including
post-translational modifications. A more global approach
was therefore adopted to study the targets of the naturally
occurring anti-parasite IgG subclass responses through
IgG subclass specific Western blot analysis of total parasite
proteins expressed in mature blood stage schizonts. Puri-
fied Parasitophorous Vacuole Membrane-Enclosed Mero-
zoite Structures (PEMS) [18] were used as a source for
parasite antigens, because PEMS preparations i) contain a
highly homogeneous synchronous parasite population at
the mature schizont stage and ii) they are essentially free
of contaminating host cell proteins.
Profiling of different naturally acquired IgG responses,
in terms of their subclass specific recognition of parasite
PEMS proteins, in individuals with different levels of
exposure to P. falciparum infection is reported. Plasma
samples were collected from four distinct sub-groups
including: Group A: non-immune Danish travellers with
as i n g l ee p i s o d eo fP. falciparum malaria; Group B:
young (0-5 years) and Group C: older (6-10 years) Gha-
naian children with frequent episodes of clinical malaria;
and Group D: clinically immune Liberian adults. A
group of non-immune Danish healthy adults (Group E)
never exposed to malaria was included as control group.
Methods
Parasite cultures and purification of PEMS
Plasmodium falciparum (F32 strain) was cultured in
vitro in human RBCs as previously described [19] using
RPMI 1640 medium supplemented with 25 mM HEPES,
20 mM NaHCO3, 2 mg/liter hypoxanthine, 0.5% (w/v)
AlbuMAX I, and 1% (v/v) penicillin-streptomycin at 5%
v/v hematocrit. Cultures were synchronized by repeated
treatment of parasites with D-sorbitol [20]. PEMS pre-
parations were purified according to the protocol of Sal-
mon et al [18]. Briefly, highly synchronized cultures at
approx. 20% parasitemia were grown until the parasites
had reached the schizont stage (> 8 nuclei stage), at
w h i c ht i m et h e yw e r et r e a t e dw i t h1 0μM E64 (Sigma,
Germany) for 8-10 h until the PEMS emerged. These
PEMS were brought into suspension, incubated for
another 2 h to allow for the vast majority of RBCs to
sediment and then purified from the supernatant by
centrifugation through 60% v/v Percoll. PEMS were col-
lected from the top of the cushion, centrifuged for 10
min at 2000 × g, washed three times in PBS containing
protease inhibitor cocktail (Roche), and stored as packed
cells at -80°C until use. The quality and homogeneity of
the purified PEMS were routinely evaluated by light
microscopy of Giemsa-stained smears and by SDS-
PAGE. When adjusted for protein concentrations and
under identical sample processing conditions, samples
from different batches showed very similar protein pat-
terns on Coomassie stained 1D-SDS-PAGE and silver
stained 2-D gels (data not shown).
Serum samples and ELISA
Plasma samples from Liberian adults clinically immune
to malaria (n = 12), Danish donors never exposed to
malaria (n = 35), and Ghanian children (n = 14) were
selected randomly from previously published studies
[21,22]. Plasma from non-immune Danish travelers (n =
7) were obtained from a routine diagnostic laboratory at
SSI. These samples were from adults who i) had experi-
enced a single attack of clinical P. falciparum malaria,
and ii) had their malaria episode confirmed by a positive
IFA test. Enzyme-linked immunosorbent assay (ELISA)
was performed essentially as described [23] using an F32
late-stage schizont extract at a coating concentration of
50 μg/ml. All plasma samples were tested at a dilution
of 1:200 in PBS, pH 7.0.
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One dimensional SDS-polyacrylamide gel electrophor-
esis (PAGE) and immunoblotting was carried out as per
standard procedures described earlier [24]. Membranes
were incubated with individual plasma samples diluted
1:200 in PBS, pH 7.4. For IgG subclass detection, mono-
clonal mouse anti-human subclasses IgG1 to IgG4
(clones NL16, HP6002, Zg4, and RJ4 [Skybio]) were
used as secondary antibodies in dilutions of 1:1000 fol-
lowed by incubation with alkaline phosphatase (AP)-
conjugated rabbit anti-mouse IgG (Dako) at 1:1000.
Statistical analysis
The differences between the distributions of parasite
antigen bands recognized by plasma IgG from different
individuals were compared by calculating two-sides P-
values based on Wilcoxons rank sum test with correc-
tion for ties. The differences between ELISA values were
compared by the u-test.
Results
Levels of naturally acquired anti-parasite IgG vary
amongst individuals with different levels of exposure to
parasite infection
Levels of parasite-specific IgG antibodies were deter-
mined in plasma from four groups of individuals who
differ in their level of exposure to malaria (Figure 1).
Levels of parasite-specific IgG antibodies were similar in
adult Liberians clinically immune to malaria and Gha-
naian children in the age-groups 0-5 and 6-10, but were
significantly higher than in non-immune Danish travel-
lers (u-test, P < 0.001). This result is in agreement with
the observation that the quantity of anti-parasite total
IgG alone cannot explain naturally acquired immunity
to P. falciparum asexual blood forms [17]. In order to
further examine whether the IgG subclass distribution
could play a role for the delayed acquisition of protec-
tive immunity, the parasite-specific IgG subclass profile
in the above mentioned groups of individuals was
characterized.
Profiling of IgG subclass responses by immunoblot
analysis of PEMS
Purified PEMS preparation was used as a source of pro-
teins expressed in mature schizonts. Microscopic exami-
nation of the PEMS preparation showed merozoite
clusters surrounded by the PVM (data not shown). Pro-
teins extracted from the PEMS preparation were sepa-
rated by SDS-PAGE and subjected to immunoblot
analysis.
Representative immunoblots displaying profiles of dif-
ferent antibody isotypes reactivity are shown in Figure 2.
Both IgG4 and IgM isotypes were found to display weak
and infrequent reactivity against parasite proteins in all
groups. Amongst the remaining antibody isotypes, the
IgG2 reactivity profile displayed a consistent pattern for
nearly all plasma samples showing reactivity against a
few high-molecular weight proteins with one protein of
approximately 70-kDa being particularly strongly recog-
nized by the majority of samples (Group A, 2/7; Group
B 5/7; Group C, 4/8; Group D, 12/12). In contrast, the
I g G 1a n dI g G 3b a n dp r o f i l e sd i f f e r e dg r e a t l yb e t w e e n
plasma samples from different exposure groups (Figure
2A-D, lane 1 and 3). Another notable observation was
the tendency for a broader IgG1 and IgG3 reactivity
with increased exposure. As shown in Table 1, the num-
ber of IgG1 reactive bands below 70-kDa was signifi-
cantly greater in clinically immune Liberians compared
to non-immune Danish travellers (Wilcoxons rank sum
test, P = 0.009). The difference between groups was
even more pronounced for the IgG3 reactivity with a
significant difference between adult Liberians and young
Ghanaian children (Wilcoxons rank sum test, P = 0.006)
and non-immune Danish travellers (Wilcoxons rank
sum test, P = 0.010). In general, Danish travellers with a
single malaria episode reacted against a few high-mole-
cular weight antigens, whereas those from Liberian
adults recognized a larger number of both high- and
low-molecular weight antigens (compare Figure 2A and
2D and Table 1). Plasma samples from the Ghanaian
children appeared to recognize an intermediate number
of bands (Figure 2B and 2C and Table 1). Thus,
Figure 1 ELISA titers against late-stage parasite extract.
Antibody levels in 7 non-immune Danish travellers with a single
episode of clinical malaria (A), 8 Ghanaian children (0-5 years) (B), 6
Ghanaian children (6-10 years) (C), 12 Liberian adults clinically
immune to malaria (D), and 35 non-immune Danish controls (E).
Each point represents one plasma sample. OD492, optical density at
492 nm. The horizontal lines mark the mean value. Open circles
mark the plasma samples for representative profiling of antibody
reactivity against parasite proteins using Western Blot analysis have
been shown (Fig. 2).
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increased antibody reactivity against wider range of low-
molecular weight parasite antigens.
Discussion
Naturally acquired immunity against malaria is highly
prevalent in adults residing in malaria endemic regions.
It is the strongest known resistance against severe clini-
cal malaria, and it develops over a long period with
repeated infections. Passive transfer of purified IgG from
hyperimmune sera to malaria patients has demonstrated
that IgG mediates anti-parasite activity and protection
against malaria. However, the mechanisms involved in
the acquisition of naturally acquired immunity and the
targets of the protective IgG have not been completely
elucidated. This report demonstrates a differential para-
site antigen reactivity of IgG responses acquired against
P. falciparum asexual blood stage antigens at different
exposure levels with a particular focus on parasite anti-
gens expressed in mature schizonts. Using parasite
PEMS preparation as the source of antigens, antigenic
profiling of the naturally acquired IgG has been carried
out using ELISA and Western Blot analysis of parasite
antigens separated by SDS PAGE. Conventionally, the
approaches widely used to study host immune response
against malaria antigens have relied on the use of
recombinant proteins or synthetic peptides usually
representing subdomains of parasite proteins which
could differ from their corresponding native parasite
counter-parts in terms of their overall structures and
post-translational modifications both of which could
potentially alter the antigenic property of the target pro-
tein. Since the selection of antigenic targets of interest
has traditionally been the first step for studying naturally
acquired immunity against malaria, very few studies
have attempted an unbiased pan-profiling of antibody
reactivity against a broad range of parasite antigens [25].
Alternatively, other studies have attempted to profile
antibody reactivity against the whole parasite extract pri-
marily through ELISA [23,26], an approach which does
not yield information regarding the molecular
Figure 2 Western blot analysis of IgG subclass responses. Asexual blood-stage F32 parasite proteins (PEMS preparation, 100 μg) were
separated by SDS-PAGE and blotted onto nitrocellulose membranes. Membranes were cut in vertical strips, blocked and incubated with
individual plasma from A) Danish travelers who have suffered a single episode of P. falciparum malaria (n = 7), B) Ghanaian children age 0-5 (n =
8), C) Ghanaian children age 6-10 (n = 6), and D) clinically immune Liberian adults (n = 12). Antibody responses were revealed with monoclonal
antibodies directed to human IgG1, IgG2, IgG3, IgG4 and IgM and visualized with AP-conjugated anti-mouse antibodies. For each of the different
groups (A to D) reactivity of two representative individual plasma samples are shown, where the one to the left was seen to have high IgG titers
determined by ELISA against late-stage parasite extract, whereas the one to the right had low IgG titers in the same assay. Western blots were
performed with different SDS-PAGE gels, all loaded with the same protein preparation (100 μg) and run under identical electrophoretic
parameters. The strips shown originate from a single blot.
Table 1 Differential immunoblot pattern of low-molecular
weight (< 70 kDa) parasite antigens detected by
cytophilic antibodies
Plasma samples Number of bands detected
(Median and interquartile
range)
Groups Composition IgG1 IgG3
A Adult Danish travelers 5.0 (4.0-6.0)
c 6.0 (3.0 - 8.0)
f
B Ghanaian children (0-5 yr) 5.5 (2.0-8.0)
b 4.0 (3.0 5.0)
e
C Ghanaian children (6-10 yr) 6.5 (6.0-8.0)
a 8.5 (4.5 - 13.5)
d
D Adult Liberians 9.0 (6.5-12.5) 14 (10.0 - 15.0)
Comparing IgG1 reactivity:
a D vs. C, P = 0.121, D vs. B
b, P = 0.094, and D vs.
A
c, P = 0.009. Comparing IgG3 reactivity:
d D vs. C, P = 0.157, D vs. B
e,P=
0.006, and D vs. A
f, P = 0.010. P-values are based on Wilcoxons rank sum test
with correction for ties.
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sera samples. Recently, protein microarray approaches
have been developed which enable antigenic analysis
against wider range of antigens, but still this technique
relies on use of recombinant proteins or synthetic pep-
tides and may suffer from the above listed limitations
[27-29]. The present approach of unbiased profiling of
naturally acquired antibodies against parasite antigens
using native parasite extract has obvious advantages
over the use of recombinant proteins or synthetic pep-
tides. As the Western blot method involves denaturing
and reducing the antigens the responses reported here
might preferentially be against denatured antigens,
whereby reactivity against some antigens characterized
by having three-dimensional epitopes could have been
missed. However, a recent study on the antibody
response against Schistosoma mansoni showed that the
antigenic profiling was the same whether antigens had
been denatured and reduced or not [30]. Other advan-
tages of using proteins from the parasite extract over
recombinant proteins or peptides would include cover-
ing all linear epitopes over the full-length protein
together with all the post-translational modifications
which could affect antigenic properties [31].
The analysis of total anti-parasite IgG in individuals
subject to different levels of exposure revealed unexpect-
edly high levels of anti-parasite IgG in the Danish travel-
lers’ plasma after a single episode of clinical malaria.
Though polyclonal activation of host B-cell response has
been suggested to be mediated by certain parasite anti-
gens [32], this does not appear to explain the profile of
the primary attack IgG subclass specific reactivity
observed in the Western blot analysis. Primary attack
plasma samples showed selective and restricted reactiv-
ity against high molecular weight parasite antigens with
IgG1, IgG2 and IgG3 responses, but very little IgG4 and
IgM reactivity, indicating activation of selected B-cell
clones rather than polyclonal activation. It is interesting
to note that the pattern of IgG2 reactivity developed
against high molecular weight antigens as a result of pri-
mary attack is also observed in plasma samples collected
from Ghanaian children and Liberian hyperimmune
individuals with multiple attacks. Additionally, increas-
ing exposure leads to a broader repertoire of P. falci-
parum reactive IgGs with the highest number of
antigens being recognized by plasma from clinically
immune Liberian adults. A degree of antigenic influence
on subclass specificity is particularly evident for the
IgG1 and IgG3 subclasses, with some bands being
recognized predominantly by IgG1 or IgG3 whilst others
are recognized by both classes. In contrast, the IgG2
antibody response seems relatively independent of host
age and exposure to P. falciparum. It appears that the
antigens recognized by IgG2 are few and in most cases
of high molecular weight (> 70 kDa). One antigen of
approximately 70 kDa was found to be particularly
strongly recognized by majority of the plasma samples
from all exposure groups. The apparently low preva-
lence of IgG2 antibodies to some malaria antigens is in
agreement with many previous reports [6,33-35]. How-
ever, the observation that the IgG2 response in general
seems independent of age and exposure is inconsistent
with the prevailing hypothesis that the initial antibody
response against P. falciparum is dominated by non-
cytophilic antibodies (IgG2/IgG4 and IgM), and that this
response gradually develops into a more protective
response dominated by cytophilic IgG1 and IgG3 anti-
bodies [17]. The data presented here suggests that the
anti-P. falciparum IgG2 response is directed against a
few high-molecular weight antigens and that the age-
dependent IgG1 and/or IgG3 responses observed against
several low-molecular weight proteins are not preceded
by corresponding IgG2 responses.
This observation suggests that clonal B-cell activation
is age and exposure dependent. It seems that upon sub-
sequent malaria attacks, additional B-cell clones are acti-
vated, which primarily generate IgG1/IgG3 responses
and which may contribute to the gradual development
of immunity. The immune response to a wide range of
antigens is weak upon the first few exposures to malaria
infections. It is likely that the parasite may produce
immune-suppressive factors [36-38] resulting in poor
immunogenicity of at least some malaria antigens. How-
ever, upon repeated exposures to malaria infection a
widened range of parasite antigens react with the devel-
oped antibodies. It is hypothesized that a first step
towards developing IgG reactivity to wide range of para-
site antigens and thus clinical protection would be to
develop effective neutralizing factors towards such para-
site encoded immune suppressive factors. This could
happen in combination with age dependent physiologi-
cal changes [39].
Results from this study suggest that the progressive
development of anti-parasite immunity in older children
is not mediated by a general switch of malaria-specific
antibodies from the non-cytophilic to the cytophilic sub-
classes. Taken together, the data suggests that the long
time required to acquire clinical protection against P.
falciparum malaria is not only related to isotype switch-
ing towards ADCI-effective antigens but also to a gra-
dual development of IgG1 and IgG3 antibodies against
some previously non-targeted antigens like the distinct
low-molecular weight P. falciparum proteins detected in
this study.
Conclusion
The present study confirms and extends previous obser-
vations suggesting that the cytophilic anti-P. falciparum
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however, subclass switching from pre-existing non-cyto-
philic antibody responses to cytophilic subclass may not
be a general phenomenon.
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